Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • MDS virtual course.png

    MJFF’s Annual Parkinson’s Course Goes Virtual to Educate Record Number of Clinicians

    MJFF recently hosted a virtual program, taught by field leaders and patients, to educate about Parkinson’s and encourage careers in the field.
    Learn more
  • Clinical Trial of Parkinson's Immunotherapy Now Recruiting

    Anxiety Drug Buspar May Be Effective but Not Well-tolerated in Parkinson’s, MJFF-Funded Trial Shows

    A small trial of the anxiety drug Buspar in people with Parkinson’s shows improved anxiety but toleration difficulties and increased motor symptoms.
    Learn more
  • Parkinson's Nilotinib Trial Enrolling Participants

    Research Roundup: Parkinson’s Clinical Trials Enrolling Participants

    Some clinical trials testing Parkinson’s treatments are recruiting volunteers again.
    Learn more
  • FW Newsletter_DAT Scan

    Making High-Impact Investments in Transformative Tools

    Learn more
  • Lab Equipment

    Biotech Deal Advances GBA Therapy for Parkinson’s

    Lysosomal Therapeutics announced sale of its therapies against dysfunction linked to mutations in the GBA gene, a common genetic cause of Parkinson’s disease.
    Learn more
  • Default content image

    Ask the PhD: Pursuing a Game-changing Brain Scan for Parkinson's 

    In our latest Ask the PhD video, we talk to staff scientist Jamie Eberling, PhD, about alpha-synuclein imaging and why we are devoting substantial resources to this area of Parkinson’s research.
    Learn more
  • ‘A Cup of Coffee a Day Keeps Dyskinesia Away?’

    Higher Caffeine Linked to Lower Parkinson’s in LRRK2 Mutation Carriers

    Recent research links higher caffeine in the blood samples and diets of people with a LRRK2 genetic mutation, which increases PD risk, with lower Parkinson’s.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.